2,300
Views
6
CrossRef citations to date
0
Altmetric
Oncology

Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US

, , , , &
Pages 1403-1407 | Received 12 Jan 2021, Accepted 10 May 2021, Published online: 03 Jun 2021